Cargando…

Profile of retinal vasculitis in a tertiary eye care center in Eastern India

AIMS: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. MATERIALS AND METHODS: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Saurabh, Kumar, Das, Radha R, Biswas, Jyotirmay, Kumar, Amitabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129755/
https://www.ncbi.nlm.nih.gov/pubmed/21666315
http://dx.doi.org/10.4103/0301-4738.81998
_version_ 1782207557141528576
author Saurabh, Kumar
Das, Radha R
Biswas, Jyotirmay
Kumar, Amitabh
author_facet Saurabh, Kumar
Das, Radha R
Biswas, Jyotirmay
Kumar, Amitabh
author_sort Saurabh, Kumar
collection PubMed
description AIMS: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. MATERIALS AND METHODS: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. RESULTS: One hundred and thirteen eyes of 70 patients of retinal vasculitis were included in this study. Sixty (85.7%) patients were male (mean age 33± 11.1 years) and 10 (14.3%) were female (mean age 32.4 ± 13.6 years). Vasculitis was bilateral in 43 (61.4%) and unilateral in 27 (38.6%) patients. Commonest symptoms were dimness of vision (73; 64.6%) and floaters (36; 31.9%). Vascular sheathing (82; 72.6%) and vitritis (51; 45.1%) were commonest signs. Mantoux test was positive in 21 (30%) patients but tuberculosis was confirmed in only four (5.71%) patients. Raised serum angiotensin-converting enzyme level and positive antinuclear antibody level were reported in four (5.71%) patients each. Human leukocyte antigen B5 (HLA B5) marker was present in one (1.4%) patient. However, none of the total 70 patients were found to have a conclusively proven systemic disease attributable as the cause of retinal vasculitis. Oral corticosteroid (60; 85.7%) was the mainstay of treatment. Forty-eight (42.5%) eyes maintained their initial visual acuity and 43 (38%) gained one or more line at mean follow-up of 16.6± 6.3 months. CONCLUSION: Retinal vasculitis cases had similar clinical presentations and common treatment plan. There was no systemic disease association with vasculitis warranting a careful approach in prescribing investigations.
format Online
Article
Text
id pubmed-3129755
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31297552011-07-11 Profile of retinal vasculitis in a tertiary eye care center in Eastern India Saurabh, Kumar Das, Radha R Biswas, Jyotirmay Kumar, Amitabh Indian J Ophthalmol Original Article AIMS: To provide a fact file on the etiology, clinical presentations and management of retinal vasculitis in Eastern India. MATERIALS AND METHODS: Retrospective, record based analysis of retinal vasculitis cases in a tertiary care center in Eastern India from January 2007 to December 2009. RESULTS: One hundred and thirteen eyes of 70 patients of retinal vasculitis were included in this study. Sixty (85.7%) patients were male (mean age 33± 11.1 years) and 10 (14.3%) were female (mean age 32.4 ± 13.6 years). Vasculitis was bilateral in 43 (61.4%) and unilateral in 27 (38.6%) patients. Commonest symptoms were dimness of vision (73; 64.6%) and floaters (36; 31.9%). Vascular sheathing (82; 72.6%) and vitritis (51; 45.1%) were commonest signs. Mantoux test was positive in 21 (30%) patients but tuberculosis was confirmed in only four (5.71%) patients. Raised serum angiotensin-converting enzyme level and positive antinuclear antibody level were reported in four (5.71%) patients each. Human leukocyte antigen B5 (HLA B5) marker was present in one (1.4%) patient. However, none of the total 70 patients were found to have a conclusively proven systemic disease attributable as the cause of retinal vasculitis. Oral corticosteroid (60; 85.7%) was the mainstay of treatment. Forty-eight (42.5%) eyes maintained their initial visual acuity and 43 (38%) gained one or more line at mean follow-up of 16.6± 6.3 months. CONCLUSION: Retinal vasculitis cases had similar clinical presentations and common treatment plan. There was no systemic disease association with vasculitis warranting a careful approach in prescribing investigations. Medknow Publications 2011 /pmc/articles/PMC3129755/ /pubmed/21666315 http://dx.doi.org/10.4103/0301-4738.81998 Text en © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saurabh, Kumar
Das, Radha R
Biswas, Jyotirmay
Kumar, Amitabh
Profile of retinal vasculitis in a tertiary eye care center in Eastern India
title Profile of retinal vasculitis in a tertiary eye care center in Eastern India
title_full Profile of retinal vasculitis in a tertiary eye care center in Eastern India
title_fullStr Profile of retinal vasculitis in a tertiary eye care center in Eastern India
title_full_unstemmed Profile of retinal vasculitis in a tertiary eye care center in Eastern India
title_short Profile of retinal vasculitis in a tertiary eye care center in Eastern India
title_sort profile of retinal vasculitis in a tertiary eye care center in eastern india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129755/
https://www.ncbi.nlm.nih.gov/pubmed/21666315
http://dx.doi.org/10.4103/0301-4738.81998
work_keys_str_mv AT saurabhkumar profileofretinalvasculitisinatertiaryeyecarecenterineasternindia
AT dasradhar profileofretinalvasculitisinatertiaryeyecarecenterineasternindia
AT biswasjyotirmay profileofretinalvasculitisinatertiaryeyecarecenterineasternindia
AT kumaramitabh profileofretinalvasculitisinatertiaryeyecarecenterineasternindia